Cobas KRAS Mutation Test by Roche Receives FDA Approval
Switzerland-based biotech company Roche has announced that it has received the U.S. Food and Drug Administration (FDA) approval for cobas […]
Switzerland-based biotech company Roche has announced that it has received the U.S. Food and Drug Administration (FDA) approval for cobas […]
The work led by Jonathan Sebat, PhD, assistant professor of psychiatry and cellular and molecular medicine at the University of California, San Diego School of Medicine poses significant and immediate implications for neurobiology and the treatment of schizophrenia.
Mutations in a gene called INF2 are by far the most common cause of a dominantly inherited condition that leads to kidney failure.